• Home
  •  / Semler Scientific

Semler Scientific

OverviewSuggest Edit

Semler Scientific, Inc. is a medical risk-assessment company whose diagnostic and testing products and services help to guide patient care and close the gap between the cost of care and compensation for care. The Company manufactures the QuantaFlo system, leading the way in Vascular Disease testing, and WellChec, a service providing assessment testing throughout the U.S. for a variety of conditions.

TypePublic
Founded2013
HQPortland, OR, USMap
Websitesemlerscientific.com
Employee Ratings4.1More
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2018)46(+25%)
Revenue (FY, 2020)$38.6 M(+18%)
Share Price (Sept 2021)$109
Cybersecurity ratingBMore

Semler Scientific Office Locations

Semler Scientific has offices in Portland and Santa Clara
Portland, OR, US (HQ)
2330 NW Everett St
Santa Clara, CA, US
2344 Walsh Ave
Show all (2)

Semler Scientific Financials and Metrics

Semler Scientific Revenue

Embed Graph
View revenue for all periods
Semler Scientific's revenue was reported to be $38.6 m in FY, 2020
USD

Revenue (Q1, 2021)

13.2m

Gross profit (Q1, 2021)

11.6m

Gross profit margin (Q1, 2021), %

88%

Net income (Q1, 2021)

4.9m

EBIT (Q1, 2021)

6.0m

Market capitalization (8-Sept-2021)

733.1m

Closing stock price (8-Sept-2021)

109.0

Cash (31-Mar-2021)

26.5m

EV

707.0m
Semler Scientific's current market capitalization is $733.1 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

3.6m7.0m7.4m12.5m21.5m32.8m38.6m

Cost of goods sold

692.0k2.8m1.9m2.6m2.1m3.7m3.4m

Gross profit

2.9m4.2m5.6m9.9m19.4m29.1m35.2m

Gross profit Margin, %

81%59%75%79%90%89%91%
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

837.0k846.0k897.0k1.2m1.3m1.6m1.5m1.6m2.0m2.1m2.6m3.6m4.5m5.5m5.6m6.8m8.0m8.9m9.4m6.4m10.7m13.2m

Cost of goods sold

155.0k172.0k178.0k220.0k244.0k385.0k417.0k533.0k398.0k540.0k592.0k724.0k704.0k489.0k587.0k569.0k591.0k974.0k850.0k700.0k820.0k1.6m

Gross profit

682.0k674.0k719.0k982.0k1.1m1.2m1.1m1.1m1.6m1.5m2.0m2.9m3.8m5.0m5.0m6.2m7.4m7.9m8.6m5.7m9.9m11.6m

Gross profit Margin, %

81%80%80%82%81%75%72%67%80%74%77%80%84%91%89%92%93%89%91%89%92%88%
show all
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

4.2m405.0k622.0k1.5m3.3m7.7m22.1m

Accounts Receivable

355.0k1.3m7.9m1.3m2.8m3.5m2.8m

Prepaid Expenses

135.0k69.0k111.0k153.0k216.0k1.4m

Current Assets

6.7m1.8m1.6m2.9m6.2m11.4m26.3m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Cash

7.6m6.6m6.0m3.1m2.3m1.9m1.4m1.0m517.0k496.0k578.0k419.0k2.0m3.1m4.5m4.2m8.5m11.2m13.6m16.8m26.5m

Accounts Receivable

157.0k127.0k311.0k356.0k262.0k439.0k599.0k607.0k897.0k885.0k1.5m2.4m1.9m2.5m2.5m3.5m3.3m1.6m982.0k3.5m4.4m

Prepaid Expenses

223.0k169.0k168.0k144.0k125.0k90.0k132.0k126.0k134.0k100.0k158.0k204.0k216.0k171.0k225.0k213.0k274.0k688.0k639.0k1.5m1.8m

Inventories

639.0k
show all
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(4.5m)(8.5m)(2.6m)(1.5m)5.0m15.1m14.0m

Depreciation and Amortization

196.0k315.0k452.0k559.0k503.0k632.0k576.0k

Accounts Payable

(167.0k)750.0k(389.0k)38.0k(208.0k)58.0k339.0k

Cash From Operating Activities

(3.8m)(4.1m)(1.8m)621.0k4.7m12.7m15.4m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income

(817.0k)(1.8m)(3.3m)(1.4m)(2.7m)(4.3m)(1.0m)(2.0m)(2.3m)(871.0k)(1.7m)(1.8m)706.0k2.2m3.6m1.9m4.5m12.3m2.7m3.7m8.6m4.9m

Depreciation and Amortization

47.0k92.0k140.0k59.0k129.0k211.0k110.0k221.0k336.0k267.0k409.0k121.0k249.0k373.0k177.0k307.0k579.0k190.0k235.0k412.0k155.0k

Inventories

(299.0k)

Accounts Payable

(116.0k)(95.0k)(39.0k)27.0k(28.0k)(449.0k)(409.0k)(558.0k)310.0k96.0k197.0k(147.0k)(303.0k)(237.0k)(23.0k)125.0k389.0k39.0k(131.0k)(2.0k)(207.0k)
show all
USDQ1, 2014

Financial Leverage

1.3 x
Show all financial metrics

Semler Scientific Cybersecurity Score

Cybersecurity ratingPremium dataset

B

87/100

Learn more about our premium products
SecurityScorecard logo

Semler Scientific Online and Social Media Presence

Semler Scientific's Trends

Embed Graph

Semler Scientific News and Updates

August 26, 2021

Semler Scientific to Present at Upcoming Investor Conferences

SANTA CLARA, Calif., Aug. 26, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that Chief Executive Officer Doug Murphy-Chutorian, M.D. and...
May 01, 2018

Semler Scientific's (SMLR) CEO Dr. Doug Murphy-Chutorian on Q1 2018 Results - Earnings Call Transcript

Semler Scientific Blogs

August 02, 2021

Semler Reports Second Quarter and First Half of 2021 Financial Results

2021 Q2 HIGHLIGHTS compared to the corresponding period of 2020: - Revenues were $14.3 million, an increase of 125% compared to $6.4 million - Pre-tax net income of $6.5 million, an increase of $5.5 million, or 554%, compared to $1.0 million - Net income was $6.7 million, or $1.00 per basic share
July 21, 2021

Semler to Report Second Quarter and First Half 2021 Financial Results and Host Conference Call on August 2, 2021

SANTA CLARA, Calif. , July 21, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the second quarter and
June 10, 2021

Semler to Participate in the Raymond James Human Health Innovation Conference

Semler to Participate in the Raymond James Human Health Innovation Conference Content Import Thu, 06/10/2021 - 08:04 Semler to Participate in the Raymond James Human Health Innovation Conference Jun 10, 2021 This release is a backfill from a News Wire …
May 03, 2021

Semler Reports First Quarter 2021 Financial Results

Semler Reports First Quarter 2021 Financial Results Content Import Mon, 05/03/2021 - 16:02 Semler Reports First Quarter 2021 Financial Results May 03, 2021 This release is a backfill from a News Wire Earnings 2021 Q1 HIGHLIGHTS comp…
April 26, 2021

Semler to Report First Quarter 2021 Financial Results and Host Conference Call on May 3, 2021

Semler to Report First Quarter 2021 Financial Results and Host Conference Call on May 3, 2021 Content Import Mon, 04/26/2021 - 08:05 Semler to Report First Quarter 2021 Financial Results and Host Conference Call on May 3, 2021 Apr 26, 2021 This release is a b…
April 07, 2021

Semler to Participate in the 20th Annual Needham Virtual Healthcare Conference

Semler to Participate in the 20th Annual Needham Virtual Healthcare Conference Content Import Wed, 04/07/2021 - 08:04 Semler to Participate in the 20th Annual Needham Virtual Healthcare Conference Apr 07, 2021 This release is a backfill from a News Wire …
Show more

 Semler Scientific Frequently Asked Questions

  • When was Semler Scientific founded?

    Semler Scientific was founded in 2013.

  • How many employees does Semler Scientific have?

    Semler Scientific has 46 employees.

  • What is Semler Scientific revenue?

    Latest Semler Scientific annual revenue is $38.6 m.

  • What is Semler Scientific revenue per employee?

    Latest Semler Scientific revenue per employee is $839.2 k.

  • Who are Semler Scientific competitors?

    Competitors of Semler Scientific include Abaxis, Clinica Tabancura and LifeHealthcare.

  • Where is Semler Scientific headquarters?

    Semler Scientific headquarters is located at 2330 NW Everett St, Portland.

  • Where are Semler Scientific offices?

    Semler Scientific has offices in Portland and Santa Clara.

  • How many offices does Semler Scientific have?

    Semler Scientific has 2 offices.